DT-Diaphorase and Mitomycin C Resistance
Author Information
Author(s): P. Workman, M.I. Walton, G. Powis, J.J. Schlager
Hypothesis
What is the role of DT-diaphorase in mitomycin C resistance?
Conclusion
DT-diaphorase may play a questionable role in mitomycin C resistance, but it could be a target for novel bioreductive drugs.
Supporting Evidence
- Human fibroblast cell line 3437T was six times more resistant to mitomycin C than the normal GM38 line.
- DT-diaphorase levels were substantially reduced in the resistant 3437T cell line.
- Dicoumarol decreased the aerobic sensitivity of the normal GM38 line but not the resistant 3437T line.
Takeaway
Some cells are resistant to a cancer drug called mitomycin C, and this might be because they don't have enough of a certain enzyme called DT-diaphorase. This enzyme could also be important for creating new cancer treatments.
Potential Biases
Concerns about over-reliance on dicoumarol as an inhibitor of DT-diaphorase may introduce bias in interpreting results.
Limitations
The role of DT-diaphorase in mitomycin C metabolism remains unclear, and the evidence is based on cytotoxicity studies rather than direct metabolic data.
Want to read the original?
Access the complete publication on the publisher's website